home / stock / apm / apm news

APM News and Press, Aptorum Group Limited From 01/10/22

Stock Information
Company Name: Aptorum Group Limited
Stock Symbol: APM
Market: NASDAQ
Website: aptorumgroup.com
Menu
APM APM Quote APM Short APM News APM Articles APM Message Board
Get APM Alerts

News, Short Squeeze, Breakout and More Instantly...
APM - Aptorum Group Announces the Launch of its Oncology and Autoimmune Discovery and Development Platform Targeting Unmet Mutations and Novel Biomarkers

Regulatory News: Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) (“Aptorum Group” or “Aptorum”), a clinical-stage biopharmaceutical company, announces the launch of its oncology and autoimmune discovery and development platform with an initial fo...
APM - Aptorum Group Limited Announces Results of 2021 Annual General Meeting of Shareholders

Regulatory News: Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) (“Aptorum Group” or “Aptorum”), a clinical stage biopharmaceutical company focused on novel technologies including the targeting of oncological diseases, announced the results of it...

APM - Aptorum Group Limited to Hold Annual General Meeting of Shareholders on December 2, 2021

Regulatory News: Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) (“Aptorum Group” or “Aptorum”), a clinical stage biopharmaceutical company focused on novel technologies including the targeting of oncological diseases, announced that it will hold...

APM - Aptorum Group Limited Interview to Air on Bloomberg U.S.

Regulatory News: Aptorum Group Limited (NASDAQ: APM, Euronext Paris: APM), a clinical stage biopharmaceutical company focused on novel technologies including the targeting of oncological diseases, today announced that an interview with President Darren Lui will air on The RedChi...
APM - MNTV, AUTL, ALLO and CLLS among after hours movers

Gainers: MNTV +14.5%. AUTL +10.9%. QDEL +7.8%. APM +6.7%. OLED +5.6%. Losers: ALLO -33.5%. CLLS -18.9%. MXCT -16.1%. CDAK -5.8%. CRBU -5.8%. For further details see: MNTV, AUTL, ALLO and CLLS among after hours movers

APM - ADVM, SCPS, HX and NUVL among after hours movers

Gainers: ADVM +13.3%. SCPS +9.7%. BIDU +4.1%. AGTC +3.9%. APM +3.5%. Losers: HX -7.3%. NUVL -4.6%. RXRX -2.2%. FA -2.1%. FLYW -1.9%. For further details see: ADVM, SCPS, HX and NUVL among after hours movers

APM - Aptorum Group Limited Reports Financial Results and Business Update for the Six Months Ended June 30, 2021

Regulatory News: Aptorum Group Limited (NASDAQ: APM, Euronext Paris: APM) (“Aptorum Group” or the “Company”), a clinical stage biopharmaceutical company dedicated to meeting unmet medical needs in oncology and infectious diseases, today provided a busines...
APM - Aptorum Group Limited Has Received IND Clearance From the US FDA to Initiate Clinical Trials for Repurposed Small Molecule Drug SACT-1 for the Treatment of Neuroblastoma

Regulatory News: Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) (“Aptorum Group” or “Aptorum”), a clinical stage biopharmaceutical company focused on novel technologies including the targeting of oncological diseases, announced that the group ha...

APM - Aptorum releases additional positive results for phase 1 antibiotic candidate

royaltystockphoto/iStock via Getty Images Aptorum Group ("APM") has announced additional positive phase 1 results for ALS-4, its candidate for Staphylococcus aureus. The new data for two additional cohorts shows that the drug was safe, well tolerated, with no serious adverse event. ALS-4 is a...

APM - Aptorum Group Announces Further Positive Interim Results of the Phase 1 Clinical Trial of ALS-4 Targeting Staphylococcus aureus

Regulatory News: Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) (“Aptorum Group” or “Aptorum”), a clinical-stage biopharmaceutical company, announces further positive results of its ongoing Phase 1 clinical trial for ALS-4 (a first in-class anti...
Previous 10 Next 10